The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of incisional umbilical hernia.It was reported that after implant of the device, the patient experienced issues that included open wound.Treatment for these issues involved application of wound vac, small bowel resection with anastomosis and enterotomy, abdominal wall closure, and placement of new mesh.After these treatments, the patient experienced vent-dependent respiratory failure from undergoing exploratory laparotomy for sma thrombosis and resection of almost the entirety of their small bowel.Provided medical records show that one week after implant of the device, the patient experienced significant issues with abdominal pain, acute mesenteric ischemia, venous congestion and thrombosis.No specific mesh-related issues were noted, and the ischemia / thrombosis treatment that spanned multiple days of icu hospitalization included removal of the mesh.Approximately two weeks after removal, new vicryl mesh was implanted.
|